title: [New strategies in anti-tumor immunotherapy].
authors.forename: Mutsunori
authors.initials: M
authors.lastname: Iga-Murahashi
authors.forename: Yasuki
authors.initials: Y
authors.lastname: Hijikata
authors.forename: Yoko
authors.initials: Y
authors.lastname: Suehiro
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Inoue
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Shinya
authors.initials: S
authors.lastname: Shimoda
authors.forename: Tomotoshi
authors.initials: T
authors.lastname: Marumoto
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Okazai
authors.forename: Koji
authors.initials: K
authors.lastname: Yoshida
authors.forename: Takuya
authors.initials: T
authors.lastname: Tsunoda
authors.forename: Kenzaburo
authors.initials: K
authors.lastname: Tani
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007376:Interleukin-2 / Q000008:administration & dosage; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D020411:Oligonucleotide Array Sequence Analysis; D050378:T-Lymphocytes, Regulatory; D022223:Vaccines, Subunit
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D007376:Interleukin-2; D022223:Vaccines, Subunit; D003520:Cyclophosphamide